Coronary artery inflammation -- Genetic basis of acute coronary syndromes -- Plaque rupture: pathoanatomical and biomechanical considerations -- Embolization as a pathological mechanism -- Plaque vulnerability (Insights from intravascular ultrasound, optical coherence tomography, and thermography) -- Differences between unstable angina and acute myocardial infarction: pathophysiological and clinical spectrum -- Acute ST-segment elevation myocardial infarction: the open artery and tissue reperfusion -- Prehospital tratment of acute myocardial infarction -- Fibrinolysis for ST elevation myocardial infarction: first and second generation agents -- Third-generation fibrinolytic agents and combined fibrinoplatelet lysis for acute myocardial infarction -- Diagnosis of acute coronary syndromes in the emergency department: evolution of chest pain centers -- Facilitated percutaneous coronary intervention for acute myocardial infarction -- Regional centers of excellence for the care of patients with acute coronary syndromes -- The role of troponin in risk stratification -- B-Type natriuretic peptides in acute coronary syndromes -- Inflammatory markers in acute coronary syndromes -- Early invasive vs. early conservative strategies for acute coronary syndromes -- Intravenous platelet glycoprotein IIb/IIIa inhibitors for acute coronary sydromes -- The role of P2Y12 blockade in acute coronary syndromes and in the catheterization laboratory -- Dosing and aspirin -- Antithrombin therapy in acute coronary syndromes -- Bedside anticoagulant testing -- Bedside platelet monitoring -- Statins and plague stabilization -- Diabetes in acute coronary syndrome -- Cardiac rupture: pathobiology, diagnosis, medical management, and surgical intervention -- Microcirculatory dysfunciton in acute myocardial infarction: evaluation, management, and treatment -- Stem cell therapy for ACS: the possibility of myocardial regeneration -- Cardiogenic shock and heart failure complicating acute myocardial infarction -- Treatment of acute myocardial infarction: international and regional differences -- Quality of coronary disease report cards -- Cost-effectiveness of new diagnostic tools and therapies for acute coronary syndromes.
0
SUMMARY OR ABSTRACT
Text of Note
"With detailed contributions from 45 renowned international authorities, this Third Edition stands alone as the most comprehensive, contemporary view of the biology, physiology, and management of acute coronary syndromes (ACS) - offering 32 chapters that span the state-of-the science in the field and provide intriguing discussions on CRP and other disease markers, microcirculation, stem cell therapy, and the development of specialized centers for ACS treatment." "Assessing the cost-efficacy and value of new diagnostic tools and therapies for ACS, this guide serves as an invaluable source for anyone engaged in the care of patients with these conditions."--BOOK JACKET.